Intra-aortic balloon pump may grant no benefit to improve the mortality of patients with acute myocardial infarction in short and long term

Medicine (United States)

Volumn 94, Issue 19, 2015, Pages

  Su, Dan ^a   Yan, Bin ^a   Guo, Litao ^a   Peng, Liyuan ^a   Wang, Xue ^a   Zeng, Lingfang ^b   Ong, HeanYee ^c   Wang, Gang ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c KHOO TECK PUAT HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; AGED; AORTA BALLOON; ARTICLE; CARDIOGENIC SHOCK; CARDIOVASCULAR MORTALITY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; EMBASE; HEART INFARCTION; HUMAN; INTRAAORTIC BALLOON PUMP; ISCHEMIC HEART DISEASE; LEFT VENTRICULAR ASSIST DEVICE; LONG TERM CARE; MEDLINE; MEMBRANE OXYGENATOR; MULTIPLE ORGAN FAILURE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; VERY ELDERLY; ACUTE DISEASE; ADVERSE EFFECTS; HEMORRHAGE; META ANALYSIS; MORTALITY; MYOCARDIAL INFARCTION; PROCEDURES; SHOCK, CARDIOGENIC;

ACUTE DISEASE; HEMORRHAGE; HUMANS; INTRA-AORTIC BALLOON PUMPING; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SHOCK, CARDIOGENIC;

EID: 84938895743     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000876     Document Type: Article

References (43)

1. Thiele H, Allam B, Chatellier G, et al. Shock in acute myocardial infarction: the Cape Horn for trials?. Eur Heart J. 2010; 31: 1828-1835
2. Aissaoui N, Puymirat E, Tabone X, et al. Improved outcome of cardiogenic shock at the acute stage of myocardial infarction: a report from the USIK 1995, USIC 2000, and FAST-MI French nationwide registries. Eur Heart J. 2012; 33: 2535-2543
3. Khera R, Cram P, Lu X, et al. Trends in the use of percutaneous ventricular assist devices: analysis of National Inpatient Sample data, 2007 through 2012 [published online ahead of print March 30, 2015]. JAMA Intern Med. 2015. doi: 10.1001/jamainternmed. 2014.7856
4. Bergh N, Angeras O, Albertsson P, et al. Does the timing of treatment with intra-aortic balloon counterpulsation in cardiogenic shock due to ST-elevation myocardial infarction affect survival?. Acute Card Care. 2014; 16: 57-62
5. Sjauw KD, Engstrom AE, Vis MM, et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines?. Eur Heart J. 2009; 30: 459-468
6. Romeo F, Acconcia MC, Sergi D, et al. The outcome of intra-aortic balloon pump support in acute myocardial infarction complicated by cardiogenic shock according to the type of revascularization: a comprehensive meta-analysis. Am Heart J. 2013; 165: 679-692
7. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2013; 82: E266-E355
8. Thiele H, Zeymer U, Neumann FJ, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. New Engl J Med. 2012; 367: 1287-1296
9. Thiele H, Zeymer U, Neumann FJ, et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet. 2013; 382: 1638-1645
10. Kolh P, Windecker S, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg. 2014; 46: 517-592
11. Higgins JP, Altman DG, Gotzsche PC, et al. The cochrane collaborations tool for assessing risk of bias in randomised trials. BMJ (Clinical research ed). 2011; 343: d5928
12. ORourke MF, Norris RM, Campbell TJ, et al. Randomized controlled trial of intraaortic balloon counterpulsation in early myocardial infarction with acute heart failure. Am J Cardiol. 1981; 47: 815-820
13. Flaherty JT, Becker LC, Weiss JL, et al. Results of a randomized prospective trial of intraaortic balloon counterpulsation and intravenous nitroglycerin in patients with acute myocardial infarction. J Am Coll Cardiol. 1985; 6: 434-446
14. Waksman R, Weiss AT, Gotsman MS, et al. Intra-aortic balloon counterpulsation improves survival in cardiogenic shock complicating acute myocardial infarction. Eur Heart J. 1993; 14: 71-74
15. Ohman EM, George BS, White CJ, et al. Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. The Randomized IABP Study Group. Circulation. 1994; 90: 792-799
16. Kono T, Morita H, Nishina T, et al. Aortic counterpulsation may improve late patency of the occluded coronary artery in patients with early failure of thrombolytic therapy. J Am Coll Cardiol. 1996; 28: 876-881
17. Stone GW, Marsalese D, Brodie BR, et al. A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. J Am Coll Cardiol. 1997; 29: 1459-1467
18. vant Hof AW, Liem AL, De Boer MJ, et al. A randomized comparison of intra-aortic balloon pumping after primary coronary angioplasty in high risk patients with acute myocardial infarction. Eur Heart J. 1999; 20: 659-665
19. Ohman EM, Nanas J, Stomel RJ, et al. Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial. J Thromb Thrombolysis. 2005; 19: 33-39
20. Li JL, Xue H, Wang BS, et al. Effect of prolonged intra-aortic balloon pumping in patients with cardiogenic shock following acute myocardial infarction. Med Sci Monit. 2007; 13: CR270-CR274
21. Vijayalakshmi K, Kunadian B, Whittaker VJ, et al. Intra-aortic counterpulsation does not improve coronary flow early after PCI in a high-risk group of patients: observations from a randomized trial to explore its mode of action. J Invasive Cardiol. 2007; 19: 339-346
22. Perera D, Stables R, Thomas M, et al. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial. JAMA. 2010; 304: 867-874
23. Prondzinsky R, Lemm H, Swyter M, et al. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med. 2010; 38: 152-160
24. Gu J, Hu W, Xiao H, et al. Prophylactic intra-aortic balloon pump reduces C-reactive protein levels and early mortality in high-risk patients undergoing percutaneous coronary intervention. Acta Cardiol. 2011; 66: 499-504
25. Patel MR, Smalling RW, Thiele H, et al. Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial. JAMA. 2011; 306: 1329-1337
26. Wu K, He S, Ye S. Primary evaluation to safety and value of IABP in patients with acute coronary syndrome complicated with pump failure. China Prac Med. 2011; 6: 6-9
27. Kern MJ, Aguirre F, Bach R, et al. Augmentation of coronary blood flow by intra-aortic balloon pumping in patients after coronary angioplasty. Circulation. 1993; 87: 500-511
28. Yan B, Peng L, Zhao X, et al. Nesiritide fails to reduce the mortality of patients with acute decompensated heart failure: an updated systematic review and cumulative meta-analysis. Int J Cardiol. 2014; 177: 505-509
29. Trost JC, Hillis LD. Intra-aortic balloon counterpulsation. Am J Cardiol. 2006; 97: 1391-1398
30. Unverzagt S, Buerke M, De Waha A, et al. Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock [published online ahead of print March 27, 2015]. Cochrane Database Syst Rev. 2015. doi: 10.1002/14651858.CD007398.pub3
31. Zangrillo A, Pappalardo F, Dossi R, et al. Preoperative intra aortic balloon pump to reduce mortality in coronary artery bypass graft: a meta-analysis of randomized controlled trials. Crit Care. 2015; 19: 10
32. Bahekar A, Singh M, Singh S, et al. Cardiovascular outcomes using intra-aortic balloon pump in high-risk acute myocardial infarction with or without cardiogenic shock: a meta-analysis. J Cardiovasc Pharmacol Ther. 2012; 17: 44-56
33. Ahmad Y, Sen S, Shun-Shin MJ, et al. Intra-aortic balloon pump therapy for acute myocardial infarction: a meta-analysis [published online ahead of print March 30, 2015]. JAMA Intern Med. 2015. doi: 10.1001/jamainternmed.2015.0569
34. Babaev A, Frederick PD, Pasta DJ, et al. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA. 2005; 294: 448-454
35. Goldberg RJ, Spencer FA, Gore JM, et al. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation. 2009; 119: 1211-1219
36. Alexander JH, Reynolds HR, Stebbins AL, et al. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. JAMA. 2007; 297: 1657-1666
37. Spencer FA, Moscucci M, Granger CB, et al. Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction?. Circulation. 2007; 116: 2793-2801
38. Kadakia MB, Desai NR, Alexander KP, et al. Use of anticoagulant agents and risk of bleeding among patients admitted with myocardial infarction: a report from the NCDR ACTION Registry -GWTG (National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry -Get With the Guidelines). JACC Cardiovasc Interv. 2010; 3: 1166-1177
39. Loh JP, Pendyala LK, Torguson R, et al. Incidence and correlates of major bleeding after percutaneous coronary intervention across different clinical presentations. Am Heart J. 2014; 168: 248-255
40. De Waha S, Desch S, Eitel I, et al. Intra-aortic balloon counterpulsation-basic principles and clinical evidence. Vascul Pharmacol. 2014; 60: 52-56
41. Davidavicius G, Godino C, Shannon J, et al. Incidence of overall bleeding in patients treated with intra-aortic balloon pump during percutaneous coronary intervention: 12-year Milan experience. JACC Cardiovasc Interv. 2012; 5: 350-357
42. Khashan MY, Pinsky MR. Does intra-aortic balloon support for myocardial infarction with cardiogenic shock improve outcome?. Crit Care. 2013; 17: 307
43. Thiele H, Schuler G, Neumann FJ, et al. Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: Design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. Am Heart J. 2015; 169: e7-8